{"transactions":[{"id":2229608,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:05:51.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":9000,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-037399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122037399/doc4.xml","form_type":"4"}},{"id":2229607,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-16T20:05:51.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":6000,"price":38.35,"value":230100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":41752,"source":{"system":"sec-edgar","filing":"0001209191-22-037399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122037399/doc4.xml","form_type":"4"}},{"id":2238748,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":24800,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238747,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":35752,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238746,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":267,"price":61.98,"value":16548.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.92 to $62.02, inclusive."}],"balance_after":25852,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238745,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":516,"price":60.99,"value":31470.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.80 to $61.41, inclusive."}],"balance_after":26119,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238744,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":1633,"price":60.23,"value":98355.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.80 to $60.76, inclusive."}],"balance_after":26635,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238743,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":2521,"price":59.08,"value":148940.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.65, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 6."}],"balance_after":28268,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2238742,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:39:33.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":2813,"price":61.374,"value":172645.062,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":30789,"source":{"system":"sec-edgar","filing":"0001209191-22-035228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035228/doc4.xml","form_type":"4"}},{"id":2494838,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-24T21:25:41.000Z","date":"2021-11-22","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date."}],"balance_after":0,"derivative":{"exercise_price":44.1,"expiration_date":"2027-06-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-21-066795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121066795/doc4.xml","form_type":"4"}},{"id":2494837,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-11-24T21:25:41.000Z","date":"2021-11-22","kind":"exercise","acquired":true,"shares":7500,"price":44.1,"value":330750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021."}],"balance_after":33602,"source":{"system":"sec-edgar","filing":"0001209191-21-066795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121066795/doc4.xml","form_type":"4"}},{"id":2671401,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:34:23.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":17500,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-040086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040086/doc4.xml","form_type":"4"}},{"id":2671400,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-06-12T00:34:23.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":25681,"source":{"system":"sec-edgar","filing":"0001209191-21-040086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040086/doc4.xml","form_type":"4"}},{"id":2677107,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:14:45.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":2117,"price":61.037,"value":129215.329,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020."}],"balance_after":18681,"source":{"system":"sec-edgar","filing":"0001209191-21-038881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121038881/doc4.xml","form_type":"4"}},{"id":3066977,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-08-05T21:16:35.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":7500,"derivative":{"exercise_price":44.1,"expiration_date":"2027-06-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-045200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120045200/doc4.xml","form_type":"4"}},{"id":3066976,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-08-05T21:16:35.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":2500,"price":52.68,"value":131700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 546 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020."}],"balance_after":20796,"source":{"system":"sec-edgar","filing":"0001209191-20-045200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120045200/doc4.xml","form_type":"4"}},{"id":3066975,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-08-05T21:16:35.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":2500,"price":44.1,"value":110250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":22750,"source":{"system":"sec-edgar","filing":"0001209191-20-045200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120045200/doc4.xml","form_type":"4"}},{"id":3094910,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":44.1,"expiration_date":"2027-06-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094909,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":22500,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094908,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094907,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":6250,"derivative":{"exercise_price":37.81,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094906,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":1778,"price":52.03,"value":92509.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.10, inclusive."}],"balance_after":20250,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094905,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":6859,"price":51.77,"value":355090.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.06 to $51.99, inclusive."}],"balance_after":22028,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094904,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":51464,"price":50.01,"value":2573714.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.94, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4."}],"balance_after":28887,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094903,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":true,"shares":30000,"price":44.1,"value":1323000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":80351,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094902,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":true,"shares":7500,"price":43.54,"value":326550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":50351,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094901,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":true,"shares":15000,"price":38.35,"value":575250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":42851,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3094900,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-07-02T01:17:24.000Z","date":"2020-06-29","kind":"exercise","acquired":true,"shares":3750,"price":37.81,"value":141787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":27851,"source":{"system":"sec-edgar","filing":"0001209191-20-039976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039976/doc4.xml","form_type":"4"}},{"id":3113096,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:30:19.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":47.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-036046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036046/doc4.xml","form_type":"4"}},{"id":3113095,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-06-11T22:30:19.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":24101,"source":{"system":"sec-edgar","filing":"0001209191-20-036046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036046/doc4.xml","form_type":"4"}},{"id":3118201,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2020-06-09T01:06:35.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":863,"price":46.331,"value":39983.653,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 597 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019 and December 2019."}],"balance_after":10101,"source":{"system":"sec-edgar","filing":"0001209191-20-035171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120035171/doc4.xml","form_type":"4"}},{"id":3498509,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T20:44:54.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-035098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035098/doc4.xml","form_type":"4"}},{"id":3498508,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2019-06-06T20:44:54.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":10367,"source":{"system":"sec-edgar","filing":"0001209191-19-035098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035098/doc4.xml","form_type":"4"}},{"id":3498507,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2019-06-06T20:44:54.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":430,"price":42.91,"value":18451.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 559 shares of common stock acquired under the issuer's employee stock purchase plan in December 2018."}],"balance_after":5367,"source":{"system":"sec-edgar","filing":"0001209191-19-035098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035098/doc4.xml","form_type":"4"}},{"id":3892144,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:18:54.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-038198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919118038198/doc4.xml","form_type":"4"}},{"id":3892143,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":126087,"kind":"person","name":"LARANJEIRA CHARLES ANTHONY","position":1,"cik":"0001524338","reported_name":"LARANJEIRA CHARLES ANTHONY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-06-15T23:18:54.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":5238,"source":{"system":"sec-edgar","filing":"0001209191-18-038198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919118038198/doc4.xml","form_type":"4"}}]}